Cargando…

How about your peers? Cystic fibrosis questionnaire data from healthy children and adolescents

BACKGROUND: The Cystic Fibrosis Questionnaire (CFQ) is widely used in research as an instrument to measure quality of life in patients with cystic fibrosis (CF). In routine patient care however, measuring quality of life is still not implemented in guidelines. One of the reasons might be the lack of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tibosch, Marijke M, Sintnicolaas, Coosje JJCM, Peters, Jeannette B, Merkus, Peter JFM, Yntema, Jan-Bart L, Verhaak, Christianne M, Vercoulen, Jan H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198681/
https://www.ncbi.nlm.nih.gov/pubmed/21989260
http://dx.doi.org/10.1186/1471-2431-11-86
_version_ 1782214470585548800
author Tibosch, Marijke M
Sintnicolaas, Coosje JJCM
Peters, Jeannette B
Merkus, Peter JFM
Yntema, Jan-Bart L
Verhaak, Christianne M
Vercoulen, Jan H
author_facet Tibosch, Marijke M
Sintnicolaas, Coosje JJCM
Peters, Jeannette B
Merkus, Peter JFM
Yntema, Jan-Bart L
Verhaak, Christianne M
Vercoulen, Jan H
author_sort Tibosch, Marijke M
collection PubMed
description BACKGROUND: The Cystic Fibrosis Questionnaire (CFQ) is widely used in research as an instrument to measure quality of life in patients with cystic fibrosis (CF). In routine patient care however, measuring quality of life is still not implemented in guidelines. One of the reasons might be the lack of consensus on how to interpret CFQ scores of an individual patient, because appropriate reference data are lacking. The question which scores reflect normal functioning and which scores reflect clinically relevant problems is still unanswered. Moreover, there is no knowledge about how healthy children and adolescents report on their quality of life (on the CFQ). With regard to quality of life the effect of normal development should be taken into account, especially in childhood and adolescence. Therefore, it is important to gain more knowledge about how healthy children and adolescents report on their quality of life and if there are any difference in a healthy populations based on age or gender. Without these data we cannot adequately interpret the CFQ as a tool in clinical care to provide patient-tailored care. Therefore this study collected data of the CFQ in healthy children and adolescents with the aim to refer health status of CF youngsters to that of healthy peers. METHODS: The CFQ was completed by 478 healthy Dutch children and adolescents (aged 6-20) in a cross-sectional study. RESULTS: The majority of healthy children (over 65%) did not reach maximum scores on most domains of the CFQ. Median CFQ-scores of healthy children and adolescents ranged from 67 to 100 (on a scale of 0-100) on the different CFQ-domains. Significant differences in quality of life exist among healthy children and adolescents, and these depend on age and gender. CONCLUSIONS: Reference data of quality of life scores from a healthy population are essential for adequate interpretation of quality of life in young patients with CF. Clinicians should be aware that the perception of health-related quality of life is not as disease-specific as one might think and also relies on factors such as age, normal maturation and gender.
format Online
Article
Text
id pubmed-3198681
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31986812011-10-23 How about your peers? Cystic fibrosis questionnaire data from healthy children and adolescents Tibosch, Marijke M Sintnicolaas, Coosje JJCM Peters, Jeannette B Merkus, Peter JFM Yntema, Jan-Bart L Verhaak, Christianne M Vercoulen, Jan H BMC Pediatr Research Article BACKGROUND: The Cystic Fibrosis Questionnaire (CFQ) is widely used in research as an instrument to measure quality of life in patients with cystic fibrosis (CF). In routine patient care however, measuring quality of life is still not implemented in guidelines. One of the reasons might be the lack of consensus on how to interpret CFQ scores of an individual patient, because appropriate reference data are lacking. The question which scores reflect normal functioning and which scores reflect clinically relevant problems is still unanswered. Moreover, there is no knowledge about how healthy children and adolescents report on their quality of life (on the CFQ). With regard to quality of life the effect of normal development should be taken into account, especially in childhood and adolescence. Therefore, it is important to gain more knowledge about how healthy children and adolescents report on their quality of life and if there are any difference in a healthy populations based on age or gender. Without these data we cannot adequately interpret the CFQ as a tool in clinical care to provide patient-tailored care. Therefore this study collected data of the CFQ in healthy children and adolescents with the aim to refer health status of CF youngsters to that of healthy peers. METHODS: The CFQ was completed by 478 healthy Dutch children and adolescents (aged 6-20) in a cross-sectional study. RESULTS: The majority of healthy children (over 65%) did not reach maximum scores on most domains of the CFQ. Median CFQ-scores of healthy children and adolescents ranged from 67 to 100 (on a scale of 0-100) on the different CFQ-domains. Significant differences in quality of life exist among healthy children and adolescents, and these depend on age and gender. CONCLUSIONS: Reference data of quality of life scores from a healthy population are essential for adequate interpretation of quality of life in young patients with CF. Clinicians should be aware that the perception of health-related quality of life is not as disease-specific as one might think and also relies on factors such as age, normal maturation and gender. BioMed Central 2011-10-11 /pmc/articles/PMC3198681/ /pubmed/21989260 http://dx.doi.org/10.1186/1471-2431-11-86 Text en Copyright ©2011 Tibosch et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tibosch, Marijke M
Sintnicolaas, Coosje JJCM
Peters, Jeannette B
Merkus, Peter JFM
Yntema, Jan-Bart L
Verhaak, Christianne M
Vercoulen, Jan H
How about your peers? Cystic fibrosis questionnaire data from healthy children and adolescents
title How about your peers? Cystic fibrosis questionnaire data from healthy children and adolescents
title_full How about your peers? Cystic fibrosis questionnaire data from healthy children and adolescents
title_fullStr How about your peers? Cystic fibrosis questionnaire data from healthy children and adolescents
title_full_unstemmed How about your peers? Cystic fibrosis questionnaire data from healthy children and adolescents
title_short How about your peers? Cystic fibrosis questionnaire data from healthy children and adolescents
title_sort how about your peers? cystic fibrosis questionnaire data from healthy children and adolescents
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198681/
https://www.ncbi.nlm.nih.gov/pubmed/21989260
http://dx.doi.org/10.1186/1471-2431-11-86
work_keys_str_mv AT tiboschmarijkem howaboutyourpeerscysticfibrosisquestionnairedatafromhealthychildrenandadolescents
AT sintnicolaascoosjejjcm howaboutyourpeerscysticfibrosisquestionnairedatafromhealthychildrenandadolescents
AT petersjeannetteb howaboutyourpeerscysticfibrosisquestionnairedatafromhealthychildrenandadolescents
AT merkuspeterjfm howaboutyourpeerscysticfibrosisquestionnairedatafromhealthychildrenandadolescents
AT yntemajanbartl howaboutyourpeerscysticfibrosisquestionnairedatafromhealthychildrenandadolescents
AT verhaakchristiannem howaboutyourpeerscysticfibrosisquestionnairedatafromhealthychildrenandadolescents
AT vercoulenjanh howaboutyourpeerscysticfibrosisquestionnairedatafromhealthychildrenandadolescents